Omkar Speciality Chemicals Q2 Results 2026: Net loss ₹1 Cr
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹0Cr
- Q2 FY26: ₹0 Cr
- Net profit
- −₹1Cr
- Q2 FY26: −₹1 Cr
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Omkar Speciality Chemicals Ltd Q2 FY27 key numbers
- Revenue
- Revenue from operations for the quarter ended 30th September 2026: ₹0 Lakhs (No revenue generated).
As stated in Omkar Speciality Chemicals Ltd's Q2 FY27 results statement · published 14 Nov 2026. Reported figures, not investment advice.
Based on Omkar Speciality Chemicals Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations for the quarter ended 30th September 2026: ₹0 Lakhs (No revenue generated). The provided document is not an results statement but the unaudited financial results and related notes for Omkar Speciality Chemicals Limited for the quarter and half year ended 30th September 2026.
From Omkar Speciality Chemicals Ltd's Q2 FY27 earnings-call transcript · updated 14 Nov 2026.
How did Omkar Speciality Chemicals' revenue grow in the September 2026 quarter?
- Revenue from operations for the quarter ended 30th September 2026: ₹0 Lakhs (No revenue generated).
- Corresponding quarter of previous year: ₹0 Lakhs (No revenue generated).
- The presentation states explicitly that the Company has not generated any revenue from operations during the quarter (Note 4, Page 7).
- Regarding outlook, the Company mentions plans to commence regular commercial operations following implementation of the Resolution Plan approved by NCLT (Note 3, Page 7), suggesting an expected future resumption of revenue generation.
What happened to Omkar Speciality Chemicals' margins in Q2 FY27?
The provided document is not an investor presentation but the unaudited financial results and related…
Locked: what Omkar Speciality Chemicals Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
What capex is Omkar Speciality Chemicals planning?
See what Omkar Speciality Chemicals Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Omkar Speciality Chemicals raising money or cutting debt?
Financing activities in the cash flow statement show:
Locked: what Omkar Speciality Chemicals Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
How big is Omkar Speciality Chemicals' order book?
See what Omkar Speciality Chemicals Ltd said on order book & pipeline — free account, 30 seconds.
Omkar Speciality Chemicals Ltd — Quarterly revenue & net profit
Omkar Speciality Chemicals Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | — | 0 | — |
| Operating profit (EBITDA) | -0 | -0 | — | -0 | — |
| Profit before tax | -1 | -1 | — | -0 | — |
| Net profit (PAT) | -1 | -1 | — | -0 | — |
| EPS (₹) | -0.47 | -0.25 | — | -0.18 | — |
Source: Omkar Speciality Chemicals Ltd's results filing to NSE (standalone), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹0 Cr, net loss ₹1 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Chemicals & Petrochemicals
Continue your research
What Omkar Speciality Chemicals's management said in earlier quarters
Earlier calls (2)
Others in Chemicals & Petrochemicals this season
- Fineotex Chem (Q2 FY27)
Quarterly Total Income from Operations: ₹391.41 crore for Q2 FY 2026–27, up 169.14% year-on-year from ₹145.43 crore. Key results statement takeaways from Fineot
- Agarwal Industrial Corporation (Q2 FY27)
Revenue from operations for the quarter ended 30.09.2026 is ₹20,857.66 Lakhs (Consolidated) and ₹20,595.73 Lakhs (Standalone). Key results statement takeaways f
- Stallion India (Q2 FY27)
Revenue from operations for the quarter ended September 30, 2026: ₹13,603.15 lakhs . Key results statement takeaways from Stallion India Fluorochemicals Ltd's Q
- Deepak Fertilisers & Petrochemicals Corp (Q2 FY27)
Q2 FY27 Operating Revenue: ₹3,334 Cr, up 11% YoY (Page 29 & 31) . Key investor presentation takeaways from Deepak Fertilisers & Petrochemicals Corp Ltd's Q2 FY2
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Omkar Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Omkar Speciality Chemicals Ltd Q2 FY27 results?
Revenue from operations for the quarter ended 30th September 2026: ₹0 Lakhs (No revenue generated). The provided document is not an results statement but the unaudited financial results and related notes for Omkar Speciality Chemicals Limited for the quarter and half year ended 30th September 2026.
What is Omkar Speciality Chemicals Ltd share price analysis?
Omkar Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹7 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Omkar Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.